» Articles » PMID: 35641907

Diagnostic Power of One-step and Two-step RT-qPCR Methods to SARS‑CoV‑2 Detection

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2022 Jun 1
PMID 35641907
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronavirus-2019 (COVID-2019) is a novel coronavirus known as Acute Respiratory Syndrome (SARS-CoV-2). The premier standard test for SARS-CoV-2 diagnosis is a one-step RT-qPCR method, which requires specific probes and reagents. Therefore, detection on a large scale is expensive and cannot be very accurate.

Methods: A cost-effective technique based on SYBR green was evaluated in the current study. The specific primers for S and N genes were designed, then performed the cross-reactivity test with other coronavirus and respiratory viruses positive samples. Moreover, the analytical sensitivity test was carried out with 8 dilutions (1:10). Lastly, the SARS-CoV-2 clinical samples (n = 210) were tested by these two methods, and receiver operating characteristic (ROC) analysis was performed to investigate the incremental diagnostic value of each gene in the study methods.

Results: The two-step method detected up to 6th dilutions of the SARS-CoV-2 samples and did not show any amplification of the positive samples of other respiratory viruses. ROC analysis revealed a diagnostic ability of the two-step method for SARS-CoV-2 with an area under the ROC curve of ≥ 0.7 (P ˂ 0.05) and relatively high sensitivity and specificity. The combination of N and S genes increased the sensitivity up to 88%, specificity up to 86%, and area under the ROC curve up to 0.85 (95% confidence interval (95% CI) 0.72 to 0.93, P = 0.0461).

Conclusion: Our findings indicated that the two-step method has comparable sensitivity and specificity to the one-step method. Therefore, this method can be considered a potential diagnostic method for diagnosing and monitoring COVID-19 patients. It suggests that when the one-step RT-qPCR method is not available, the two-step RT-qPCR can be used to identify SARS-CoV-2.

Citing Articles

A one-step low-cost molecular test for SARS-CoV-2 detection suitable for community testing using minimally processed saliva.

da Silva S, Amaral C, Malta-Luis C, Grilo D, Duarte A, Morais I Biol Methods Protoc. 2024; 9(1):bpae035.

PMID: 38835855 PMC: 11147803. DOI: 10.1093/biomethods/bpae035.


An Open One-Step RT-qPCR for SARS-CoV-2 detection.

Cerda A, Rivera M, Armijo G, Ibarra-Henriquez C, Reyes J, Blazquez-Sanchez P PLoS One. 2024; 19(1):e0297081.

PMID: 38271448 PMC: 10810446. DOI: 10.1371/journal.pone.0297081.


Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.

Chung P, Dhillon S, Simoens C, Cuypers L, Laenen L, Bonde J Microbiol Spectr. 2024; 12(2):e0239723.

PMID: 38189291 PMC: 10846132. DOI: 10.1128/spectrum.02397-23.

References
1.
Freire-Paspuel B, Vega-Marino P, Velez A, Cruz M, Garcia-Bereguiain M . "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit". Virus Res. 2020; 290:198173. PMC: 7513759. DOI: 10.1016/j.virusres.2020.198173. View

2.
Tajadini M, Panjehpour M, Javanmard S . Comparison of SYBR Green and TaqMan methods in quantitative real-time polymerase chain reaction analysis of four adenosine receptor subtypes. Adv Biomed Res. 2014; 3:85. PMC: 3988599. DOI: 10.4103/2277-9175.127998. View

3.
. Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea. Osong Public Health Res Perspect. 2020; 11(1):8-14. PMC: 7045878. DOI: 10.24171/j.phrp.2020.11.1.03. View

4.
Liang Y, Wang M, Chien C, Yarmishyn A, Yang Y, Lai W . Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Front Immunol. 2020; 11:1022. PMC: 7236801. DOI: 10.3389/fimmu.2020.01022. View

5.
Jiang M, Pan W, Arasthfer A, Fang W, Ling L, Fang H . Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of COVID-19. Front Cell Infect Microbiol. 2020; 10:331. PMC: 7313420. DOI: 10.3389/fcimb.2020.00331. View